08:39 AM EDT, 07/19/2024 (MT Newswires) -- Dare Bioscience ( DARE ) said Friday that it has regained compliance with Nasdaq's minimum bid price requirements.

The biopharmaceutical company said its closing bid price remained at least $1 per share for 10 consecutive business days.

Shares of the company were up less than 1% in recent Friday premarket activity.

Price: 3.2200, Change: +0.03, Percent Change: +0.94